应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NXTC Nextcure Inc.
盘前交易 12-20 05:10:05 EST
0.9500
+0.0600
+6.74%
最高
1.00
最低
0.8900
成交量
4.87万
今开
0.9400
昨收
0.8900
日振幅
12.36%
总市值
2,661万
流通市值
1,715万
总股本
2,801万
成交额
4.53万
换手率
0.27%
流通股本
1,806万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Nextcure, Inc.盘中异动 股价大跌5.97%
市场透视 · 12-17 23:45
Nextcure, Inc.盘中异动 股价大跌5.97%
Nextcure, Inc.盘中异动 急速下挫5.56%报1.02美元
市场透视 · 12-16
Nextcure, Inc.盘中异动 急速下挫5.56%报1.02美元
Nextcure, Inc.盘中异动 下午盘股价大跌5.31%
市场透视 · 12-13
Nextcure, Inc.盘中异动 下午盘股价大跌5.31%
Nextcure, Inc.盘中异动 下午盘急速下挫6.03%报1.09美元
市场透视 · 12-11
Nextcure, Inc.盘中异动 下午盘急速下挫6.03%报1.09美元
Nextcure, Inc.盘中异动 急速下跌5.26%报1.08美元
市场透视 · 12-09
Nextcure, Inc.盘中异动 急速下跌5.26%报1.08美元
Nextcure, Inc.盘中异动 临近收盘股价大跌8.26%
市场透视 · 12-07
Nextcure, Inc.盘中异动 临近收盘股价大跌8.26%
Nextcure, Inc.盘中异动 下午盘大幅跳水5.22%
市场透视 · 12-06
Nextcure, Inc.盘中异动 下午盘大幅跳水5.22%
Nextcure, Inc.盘中异动 早盘股价大涨6.19%报1.20美元
市场透视 · 12-04
Nextcure, Inc.盘中异动 早盘股价大涨6.19%报1.20美元
Nextcure, Inc.盘中异动 快速上涨5.17%
市场透视 · 12-03
Nextcure, Inc.盘中异动 快速上涨5.17%
Nextcure, Inc.盘中异动 急速跳水6.67%报1.12美元
市场透视 · 11-27
Nextcure, Inc.盘中异动 急速跳水6.67%报1.12美元
Nextcure, Inc.盘中异动 临近午盘股价大跌5.43%
市场透视 · 11-23
Nextcure, Inc.盘中异动 临近午盘股价大跌5.43%
Nextcure, Inc.盘中异动 早盘快速拉升5.34%报1.38美元
市场透视 · 11-21
Nextcure, Inc.盘中异动 早盘快速拉升5.34%报1.38美元
Nextcure, Inc.盘中异动 早盘大幅上涨6.20%
市场透视 · 11-19
Nextcure, Inc.盘中异动 早盘大幅上涨6.20%
Nextcure, Inc.盘中异动 下午盘快速跳水5.67%报1.33美元
市场透视 · 11-15
Nextcure, Inc.盘中异动 下午盘快速跳水5.67%报1.33美元
Nextcure, Inc.盘中异动 下午盘股价大跌5.19%
市场透视 · 11-14
Nextcure, Inc.盘中异动 下午盘股价大跌5.19%
Nextcure, Inc.盘中异动 早盘股价大涨5.88%
市场透视 · 11-12
Nextcure, Inc.盘中异动 早盘股价大涨5.88%
Nextcure, Inc.盘中异动 股价大涨8.53%
市场透视 · 11-11
Nextcure, Inc.盘中异动 股价大涨8.53%
Nextcure, Inc.2024财年第三财季实现净利润-11.54百万美元,同比增加19.30%
市场透视 · 11-09
Nextcure, Inc.2024财年第三财季实现净利润-11.54百万美元,同比增加19.30%
NextCure Inc 预计每股亏损 34 美分 - 财报前瞻
Reuters · 10-29
NextCure Inc 预计每股亏损 34 美分 - 财报前瞻
Nextcure, Inc.盘中异动 快速拉升5.97%
市场透视 · 10-23
Nextcure, Inc.盘中异动 快速拉升5.97%
加载更多
公司概况
公司名称:
Nextcure Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
NextCure, Inc.于2015年9月在特拉华州注册成立,总部位于马里兰州贝尔茨维尔。 该公司是一家临床阶段的生物制药公司,致力于发现和开发新型的一流免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。 通过其专有的功能性,集成式,免疫肿瘤学中的NextCure Discovery(“FIND-IO”)平台,公司研究各种免疫细胞,以发现和了解免疫细胞的靶标和结构成分及其功能影响,从而开发免疫组化。
发行价格:
--
{"stockData":{"symbol":"NXTC","market":"US","secType":"STK","nameCN":"Nextcure Inc.","latestPrice":0.95,"timestamp":1734642000000,"preClose":0.89,"halted":0,"volume":48688,"delay":0,"floatShares":18055567,"shares":28006684,"eps":-2.094523,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.06,"latestTime":"12-20 05:10:05 EST","open":0.94,"high":1,"low":0.89,"amount":45318.834219,"amplitude":0.123596,"askPrice":1.13,"askSize":100,"bidPrice":0.814,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.094523,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734705000000},"adr":0,"listingDate":1557374400000,"adjPreClose":0.95,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":0.95,"preClose":0.95,"latestTime":"16:00 EST","volume":79,"amount":75.05,"timestamp":1734642001220},"volumeRatio":0.282873071782965,"impliedVol":1.471,"impliedVolPercentile":0.5817},"requestUrl":"/m/hq/s/NXTC","defaultTab":"news","newsList":[{"id":"2492996437","title":"Nextcure, Inc.盘中异动 股价大跌5.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492996437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492996437?lang=zh_cn&edition=full","pubTime":"2024-12-17 23:45","pubTimestamp":1734450346,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日23时45分,Nextcure, Inc.股票出现异动,股价急速跳水5.97%。Nextcure, Inc.股票所在的生物技术行业中,整体涨幅为0.46%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段生物制药公司,致力于发现和开发新型,一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217234546a1f62c56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217234546a1f62c56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0456854461.SGD","NXTC","CRC","BK4213","LU0266512127.USD"],"gpt_icon":0},{"id":"2491961823","title":"Nextcure, Inc.盘中异动 急速下挫5.56%报1.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491961823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491961823?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:56","pubTimestamp":1734360981,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时56分,Nextcure, Inc.股票出现波动,股价大幅跳水5.56%。截至发稿,该股报1.02美元/股,成交量3.0484万股,换手率0.11%,振幅3.70%。Nextcure, Inc.股票所在的生物技术行业中,整体涨幅为0.66%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段生物制药公司,致力于发现和开发新型,一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216225621ab7ca04b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216225621ab7ca04b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRC","BK4139","LU0266512127.USD","LU0456854461.SGD","BK4213","NXTC"],"gpt_icon":0},{"id":"2491538833","title":"Nextcure, Inc.盘中异动 下午盘股价大跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491538833","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491538833?lang=zh_cn&edition=full","pubTime":"2024-12-13 02:51","pubTimestamp":1734029465,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日02时51分,Nextcure, Inc.股票出现波动,股价快速下挫5.31%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为1.00%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段生物制药公司,致力于发现和开发新型,一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213025105984b9fd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213025105984b9fd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRC","LU0266512127.USD","LU0456854461.SGD","NXTC","BK4213"],"gpt_icon":0},{"id":"2490028203","title":"Nextcure, Inc.盘中异动 下午盘急速下挫6.03%报1.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490028203","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490028203?lang=zh_cn&edition=full","pubTime":"2024-12-11 04:14","pubTimestamp":1733861646,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日04时14分,Nextcure, Inc.股票出现波动,股价急速下挫6.03%。截至发稿,该股报1.09美元/股,成交量5.7893万股,换手率0.21%,振幅8.62%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为0.52%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段生物制药公司,致力于发现和开发新型,一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211041406984b1c33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211041406984b1c33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRC","LU0266512127.USD","LU0456854461.SGD","NXTC","BK4213"],"gpt_icon":0},{"id":"2490775182","title":"Nextcure, Inc.盘中异动 急速下跌5.26%报1.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490775182","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490775182?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:30","pubTimestamp":1733754633,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日22时30分,Nextcure, Inc.股票出现波动,股价快速跳水5.26%。Nextcure, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段生物制药公司,致力于发现和开发新型,一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223033ab6a08f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223033ab6a08f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4213","CRC","BK4139","NXTC","LU0456854461.SGD","LU0266512127.USD"],"gpt_icon":0},{"id":"2489589266","title":"Nextcure, Inc.盘中异动 临近收盘股价大跌8.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489589266","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489589266?lang=zh_cn&edition=full","pubTime":"2024-12-07 04:39","pubTimestamp":1733517593,"startTime":"0","endTime":"0","summary":"北京时间2024年12月07日04时39分,Nextcure, Inc.股票出现异动,股价快速跳水8.26%。Nextcure, Inc.股票所在的生物技术行业中,整体涨幅为0.13%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段生物制药公司,致力于发现和开发新型,一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241207043954a1da1a14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241207043954a1da1a14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0266512127.USD","NXTC","BK4213","CRC","LU0456854461.SGD"],"gpt_icon":0},{"id":"2489497361","title":"Nextcure, Inc.盘中异动 下午盘大幅跳水5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489497361","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489497361?lang=zh_cn&edition=full","pubTime":"2024-12-06 04:04","pubTimestamp":1733429065,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日04时04分,Nextcure, Inc.股票出现波动,股价快速下跌5.22%。Nextcure, Inc.股票所在的生物技术行业中,整体涨幅为0.12%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段生物制药公司,致力于发现和开发新型,一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206040425971beec9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206040425971beec9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0456854461.SGD","NXTC","LU0266512127.USD","BK4139","BK4213","CRC"],"gpt_icon":0},{"id":"2488978131","title":"Nextcure, Inc.盘中异动 早盘股价大涨6.19%报1.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488978131","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488978131?lang=zh_cn&edition=full","pubTime":"2024-12-04 22:42","pubTimestamp":1733323322,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日22时42分,Nextcure, Inc.股票出现波动,股价急速拉升6.19%。截至发稿,该股报1.20美元/股,成交量576股,换手率0.00%,振幅0.00%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为0.19%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段生物制药公司,致力于发现和开发新型,一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204224203971ba0df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204224203971ba0df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4213","NXTC","CRC","LU0456854461.SGD","LU0266512127.USD"],"gpt_icon":0},{"id":"2488946544","title":"Nextcure, Inc.盘中异动 快速上涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488946544","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488946544?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:34","pubTimestamp":1733236447,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时34分,Nextcure, Inc.股票出现异动,股价大幅拉升5.17%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为0.04%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段生物制药公司,致力于发现和开发新型,一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223407a269970b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223407a269970b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0266512127.USD","LU0456854461.SGD","NXTC","BK4213","CRC"],"gpt_icon":0},{"id":"2486399478","title":"Nextcure, Inc.盘中异动 急速跳水6.67%报1.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486399478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486399478?lang=zh_cn&edition=full","pubTime":"2024-11-27 04:43","pubTimestamp":1732653784,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日04时43分,Nextcure, Inc.股票出现波动,股价快速跳水6.67%。截至发稿,该股报1.12美元/股,成交量32.6611万股,换手率1.17%,振幅7.39%。Nextcure, Inc.股票所在的生物技术行业中,整体涨幅为0.36%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段生物制药公司,致力于发现和开发新型,一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112704430498e44c04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112704430498e44c04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRC","NXTC","LU0266512127.USD","BK4213","LU0456854461.SGD"],"gpt_icon":0},{"id":"2485867296","title":"Nextcure, Inc.盘中异动 临近午盘股价大跌5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485867296","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485867296?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:45","pubTimestamp":1732293953,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日00时45分,Nextcure, Inc.股票出现异动,股价快速下跌5.43%。Nextcure, Inc.股票所在的生物技术行业中,整体涨幅为0.71%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段生物制药公司,致力于发现和开发新型,一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112300455498e44330&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112300455498e44330&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4213","NXTC","LU0266512127.USD","BK4139","LU0456854461.SGD","CRC"],"gpt_icon":0},{"id":"2485149496","title":"Nextcure, Inc.盘中异动 早盘快速拉升5.34%报1.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485149496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485149496?lang=zh_cn&edition=full","pubTime":"2024-11-21 00:05","pubTimestamp":1732118704,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日00时05分,Nextcure, Inc.股票出现波动,股价快速拉升5.34%。截至发稿,该股报1.38美元/股,成交量1190股,换手率0.00%,振幅1.90%。Nextcure, Inc.股票所在的生物技术行业中,整体涨幅为0.93%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段生物制药公司,致力于发现和开发新型,一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121000504971a7b9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121000504971a7b9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0266512127.USD","BK4213","NXTC","BK4139","LU0456854461.SGD","CRC"],"gpt_icon":0},{"id":"2484029928","title":"Nextcure, Inc.盘中异动 早盘大幅上涨6.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484029928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484029928?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:34","pubTimestamp":1732026842,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日22时34分,Nextcure, Inc.股票出现异动,股价快速拉升6.20%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为0.64%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段生物制药公司,致力于发现和开发新型,一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111922340295be4af4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111922340295be4af4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0266512127.USD","BK4139","BK4213","LU0456854461.SGD","NXTC","CRC"],"gpt_icon":0},{"id":"2483311393","title":"Nextcure, Inc.盘中异动 下午盘快速跳水5.67%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483311393","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483311393?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:15","pubTimestamp":1731615330,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时15分,Nextcure, Inc.股票出现波动,股价快速下挫5.67%。截至发稿,该股报1.33美元/股,成交量2.7137万股,换手率0.10%,振幅7.20%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为1.35%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段生物制药公司,致力于发现和开发新型,一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111504153098e42b95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111504153098e42b95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4213","NXTC","LU0266512127.USD","BK4139","LU0456854461.SGD","CRC"],"gpt_icon":0},{"id":"2483685538","title":"Nextcure, Inc.盘中异动 下午盘股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483685538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483685538?lang=zh_cn&edition=full","pubTime":"2024-11-14 02:32","pubTimestamp":1731522778,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日02时32分,Nextcure, Inc.股票出现波动,股价快速跳水5.19%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为0.27%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段生物制药公司,致力于发现和开发新型,一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114023258971a65af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114023258971a65af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0456854461.SGD","NXTC","LU0266512127.USD","BK4139","BK4213","CRC"],"gpt_icon":0},{"id":"2482085074","title":"Nextcure, Inc.盘中异动 早盘股价大涨5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482085074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482085074?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:31","pubTimestamp":1731421867,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时31分,Nextcure, Inc.股票出现异动,股价快速拉升5.88%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为0.10%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段生物制药公司,致力于发现和开发新型,一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111222310798e420fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111222310798e420fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0266512127.USD","BK4213","NXTC","BK4139","LU0456854461.SGD","CRC"],"gpt_icon":0},{"id":"2482420738","title":"Nextcure, Inc.盘中异动 股价大涨8.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482420738","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482420738?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:31","pubTimestamp":1731335465,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时31分,Nextcure, Inc.股票出现异动,股价快速拉升8.53%。截至发稿,该股报1.40美元/股,成交量2.7382万股,换手率0.10%,振幅2.33%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为0.05%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段生物制药公司,致力于发现和开发新型,一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122310695be100d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122310695be100d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4213","CRC","BK4139","LU0456854461.SGD","NXTC","LU0266512127.USD"],"gpt_icon":0},{"id":"2482665084","title":"Nextcure, Inc.2024财年第三财季实现净利润-11.54百万美元,同比增加19.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482665084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482665084?lang=zh_cn&edition=full","pubTime":"2024-11-09 08:01","pubTimestamp":1731110514,"startTime":"0","endTime":"0","summary":"11月9日,Nextcure, Inc.公布财报,公告显示公司2024财年第三财季净利润为-11.54百万美元,同比增加19.30%;其中营业收入为0.00美元,每股基本收益为-0.41美元。从资产负债表来看,Nextcure, Inc.总负债14.75百万美元,其中短期债务284000.00美元,资产负债比为6.13,流动比率为9.08。机构评级:截至2024年11月9日,当前有3家机构对Nextcure, Inc.目标价做出预测,其中目标均价为3.33美元,其中最低目标价为3.00美元,最高目标价为4.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109080204abaf32d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109080204abaf32d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NXTC"],"gpt_icon":0},{"id":"2479470704","title":"NextCure Inc 预计每股亏损 34 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2479470704","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479470704?lang=zh_cn&edition=full","pubTime":"2024-10-29 19:18","pubTimestamp":1730200703,"startTime":"0","endTime":"0","summary":" * NextCure公司 预计在10月31日发布业绩报告时,季度收入将没有变化(预计),截至2024年9月30日。* * LSEG分析师对NextCure公司的平均预期是每股亏损34美分。* 华尔街对 NextCure 公司 12 个月目标价的中位数为 4.00 美元,高于上一次收盘价 1.36 美元。10月29日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"NextCure Inc 预计每股亏损 34 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC"],"gpt_icon":0},{"id":"2477654393","title":"Nextcure, Inc.盘中异动 快速拉升5.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477654393","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477654393?lang=zh_cn&edition=full","pubTime":"2024-10-23 01:36","pubTimestamp":1729618604,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日01时36分,Nextcure, Inc.股票出现异动,股价大幅拉升5.97%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为1.14%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段生物制药公司,致力于发现和开发新型,一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023013645a1e2d8fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023013645a1e2d8fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4213","CRC","BK4139","LU0456854461.SGD","NXTC","LU0266512127.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nextcure.com","stockEarnings":[{"period":"1week","weight":-0.1284},{"period":"1month","weight":-0.2748},{"period":"3month","weight":-0.3116},{"period":"6month","weight":-0.4136},{"period":"1year","weight":-0.1667},{"period":"ytd","weight":-0.1667}],"compareEarnings":[{"period":"1week","weight":-0.0302},{"period":"1month","weight":-0.0071},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.0764},{"period":"1year","weight":0.2517},{"period":"ytd","weight":0.2331}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NextCure, Inc.于2015年9月在特拉华州注册成立,总部位于马里兰州贝尔茨维尔。 该公司是一家临床阶段的生物制药公司,致力于发现和开发新型的一流免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。 通过其专有的功能性,集成式,免疫肿瘤学中的NextCure Discovery(“FIND-IO”)平台,公司研究各种免疫细胞,以发现和了解免疫细胞的靶标和结构成分及其功能影响,从而开发免疫组化。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.001026},{"month":2,"riseRate":0.2,"avgChangeRate":0.036577},{"month":3,"riseRate":0.2,"avgChangeRate":0.000909},{"month":4,"riseRate":0.2,"avgChangeRate":-0.166095},{"month":5,"riseRate":0.4,"avgChangeRate":0.041415},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.033582},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.060834},{"month":8,"riseRate":0.5,"avgChangeRate":0.066323},{"month":9,"riseRate":0,"avgChangeRate":-0.127012},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.032937},{"month":11,"riseRate":0.5,"avgChangeRate":0.052168},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.001109}],"exchange":"NASDAQ","name":"Nextcure Inc.","nameEN":"Nextcure Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nextcure Inc.(NXTC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nextcure Inc.(NXTC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nextcure Inc.,NXTC,Nextcure Inc.股票,Nextcure Inc.股票老虎,Nextcure Inc.股票老虎国际,Nextcure Inc.行情,Nextcure Inc.股票行情,Nextcure Inc.股价,Nextcure Inc.股市,Nextcure Inc.股票价格,Nextcure Inc.股票交易,Nextcure Inc.股票购买,Nextcure Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nextcure Inc.(NXTC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nextcure Inc.(NXTC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}